{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:31:34Z","timestamp":1793705494424,"version":"4.5.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.semperi.2024.152006","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T10:08:00Z","timestamp":1731838080000},"page":"152006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of genetics in neonatal abstinence syndrome"],"prefix":"10.1016","volume":"49","author":[{"given":"Sarah","family":"Vernovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Herning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha M.","family":"Wachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semperi.2024.152006_bib0001","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.semperi.2024.152006_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpeds.2021.12.021","article-title":"Standardizing the clinical definition of opioid withdrawal in the neonate","volume":"243","author":"Jilani","year":"2022","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.semperi.2024.152006_bib0003","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-029074","article-title":"Committee on fetus and newborn, committee on substance use and prevention. Neonatal opioid withdrawal syndrome","volume":"146","author":"Patrick","year":"2020","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.semperi.2024.152006_bib0004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/aje\/kwu190","article-title":"Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis","volume":"180","author":"Brogly","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.semperi.2024.152006_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28588","article-title":"Characteristics of prescription opioid analgesics in pregnancy and risk of neonatal opioid withdrawal syndrome in newborns","volume":"5","author":"Esposito","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semperi.2024.152006_bib0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2018.07.024","article-title":"Impact of psychiatric medication co-exposure on neonatal abstinence syndrome severity","volume":"192","author":"Wachman","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"10.1016\/j.semperi.2024.152006_bib0007","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1360-0443.2012.04038.x","article-title":"Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication","volume":"107","author":"Kaltenbach","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.semperi.2024.152006_bib0008","article-title":"Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database","volume":"19","author":"Singh","year":"2021","journal-title":"J Perinatol"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/pediatric14010009","article-title":"Gestational age alters assessment of neonatal abstinence syndrome","volume":"14","author":"Amiri","year":"2022","journal-title":"Pediatr Rep"},{"issue":"6","key":"10.1016\/j.semperi.2024.152006_bib0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1542\/hpeds.2016-0218","article-title":"Male sex associated with increased risk of neonatal abstinence syndrome","volume":"7","author":"Charles","year":"2017","journal-title":"Hosp Pediatr"},{"issue":"5","key":"10.1016\/j.semperi.2024.152006_bib0011","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1111\/apa.12910","article-title":"Prematurity reduces the severity and need for treatment of neonatal abstinence syndrome","volume":"104","author":"Ruwanpathirana","year":"2015","journal-title":"Acta Paediatr"},{"issue":"5","key":"10.1016\/j.semperi.2024.152006_bib0012","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/1552-6909.12242","article-title":"Breastfeeding promotion for management of neonatal abstinence syndrome","volume":"42","author":"Pritham","year":"2013","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"4","key":"10.1016\/j.semperi.2024.152006_bib0013","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jogn.2019.03.004","article-title":"Systematic review of newborn feeding method and outcomes related to neonatal abstinence syndrome","volume":"48","author":"McQueen","year":"2019","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"4","key":"10.1016\/j.semperi.2024.152006_bib0014","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.semperi.2024.152006_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1542\/hpeds.2016-0147","article-title":"Impact of parental presence at infants\u2019 bedside on neonatal abstinence syndrome","volume":"7","author":"Howard","year":"2017","journal-title":"Hosp Pediatr"},{"issue":"8","key":"10.1016\/j.semperi.2024.152006_bib0016","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1055\/s-0043-1778008","article-title":"Hair cortisol concentrations in opioid-exposed versus nonexposed mother-infant dyads","volume":"41","author":"Morrison","year":"2024","journal-title":"Am J Perinatol"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0017","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/10998004241242102","article-title":"Gut Microbiota and symptom expression and severity in neonatal abstinence syndrome","volume":"26","author":"Sealschott","year":"2024","journal-title":"Biol Res Nurs"},{"issue":"10","key":"10.1016\/j.semperi.2024.152006_bib0018","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2217\/pgs.12.94","article-title":"Epigenetics of drug abuse: predisposition or response","volume":"13","author":"Nielsen","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"7","key":"10.1016\/j.semperi.2024.152006_bib0019","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1360-0443.2008.02213.x","article-title":"Are there genetic influences on addiction: evidence from family, adoption and twin studies","volume":"103","author":"Agrawal","year":"2008","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.57.3.261","article-title":"Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins","volume":"57","author":"Kendler","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0021","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/jcm9010180","article-title":"Genome-wide association study of opioid cessation","volume":"9","author":"Cox","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0022","first-page":"37","article-title":"A review of genome-wide association studies of stimulant and opioid use disorders","volume":"2","author":"Jensen","year":"2016","journal-title":"Mol Neuropsychiatry"},{"key":"10.1016\/j.semperi.2024.152006_bib0023","first-page":"361","article-title":"OPRM1 A118G polymorphisms and its role in opioid addiction: implication on severity and treatment approaches","volume":"12","author":"Taqi","year":"2019","journal-title":"Pharmgenomics Pers Med"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0024","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Dopamine, immunity, and disease","volume":"75","author":"Channer","year":"2023","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.semperi.2024.152006_bib0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.psc.2012.03.010","article-title":"The genetic basis of addictive disorders","volume":"35","author":"Ducci","year":"2012","journal-title":"Psychiatr Clin North Am"},{"issue":"6","key":"10.1016\/j.semperi.2024.152006_bib0026","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1089\/gtmb.2021.0280","article-title":"Significant association of the Catechol-O-methyltransferase gene polymorphism (rs4680) and opioid use disorder in Asian populations, but not caucasian populations: a meta-analysis","volume":"26","author":"Huang","year":"2022","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0027","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/s41598-019-41110-7","article-title":"Genomewide study of epigenetic biomarkers of opioid dependence in european- American women","volume":"9","author":"Montalvo-Ortiz","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.semperi.2024.152006_bib0028","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/npp.2008.108","article-title":"Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts","volume":"34","author":"Nielsen","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.semperi.2024.152006_bib0029","article-title":"CpH methylome analysis in human cortical neurons identifies novel gene pathways and drug targets for opioid use disorder","volume":"13","author":"Nagamatsu","year":"2022","journal-title":"Front Psychiatry"},{"issue":"17","key":"10.1016\/j.semperi.2024.152006_bib0030","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2013.3411","article-title":"Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome","volume":"309","author":"Wachman","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.semperi.2024.152006_bib0031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2015.07.001","article-title":"Variations in opioid receptor genes in neonatal abstinence syndrome","volume":"155","author":"Wachman","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"10.1016\/j.semperi.2024.152006_bib0032","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00008571-200412000-00002","article-title":"Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction","volume":"14","author":"Yuferov","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.semperi.2024.152006_bib0033","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.copsyc.2018.07.014","article-title":"A review of opioid addiction genetics","volume":"27","author":"Crist","year":"2019","journal-title":"Curr Opin Psychol"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0034","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ajad.12483","article-title":"Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity","volume":"26","author":"Wachman","year":"2017","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.semperi.2024.152006_bib0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.brainresbull.2011.11.012","article-title":"Effects of COMT polymorphisms on brain function and behavior in health and disease","volume":"88","author":"Witte","year":"2012","journal-title":"Brain Res Bull"},{"issue":"9","key":"10.1016\/j.semperi.2024.152006_bib0036","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1055\/s-0037-1600917","article-title":"Variations in infant CYP2B6 genotype associated with the need for pharmacological treatment for Neonatal abstinence syndrome in infants of methadone-maintained opioid-dependent mothers","volume":"34","author":"Mactier","year":"2017","journal-title":"Am J Perinatol"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0037","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ahg.12046","article-title":"The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction: DRD2 and opioid addiction","volume":"78","author":"Clarke","year":"2014","journal-title":"Ann Hum Genet"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0038","doi-asserted-by":"crossref","first-page":"F193","DOI":"10.1136\/archdischild-2011-300235","article-title":"Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women","volume":"97","author":"Oei","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"7","key":"10.1016\/j.semperi.2024.152006_bib0039","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat Rev Genet"},{"issue":"14","key":"10.1016\/j.semperi.2024.152006_bib0040","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00003088-200443140-00003","article-title":"Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives: Clinical utility and future perspectives","volume":"43","author":"L\u00f6tsch","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.semperi.2024.152006_bib0041","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clpt.2006.09.011","article-title":"ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals","volume":"80","author":"Coller","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"14","key":"10.1016\/j.semperi.2024.152006_bib0042","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/ddn122","article-title":"ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence","volume":"17","author":"Levran","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0043","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biopsych.2013.08.034","article-title":"Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways","volume":"76","author":"Gelernter","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.semperi.2024.152006_bib0044","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/mp.2015.102","article-title":"Evidence of CNIH3 involvement in opioid dependence","volume":"21","author":"Nelson","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"8","key":"10.1016\/j.semperi.2024.152006_bib0045","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41380-020-0677-9","article-title":"Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium","volume":"25","author":"Polimanti","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"10","key":"10.1016\/j.semperi.2024.152006_bib0046","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/jamapsychiatry.2020.1206","article-title":"Association of OPRM1 functional coding variant with opioid use disorder: a genome-wide association study: a genome-wide association study","volume":"77","author":"Zhou","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.semperi.2024.152006_bib0047","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1038\/s41380-021-01335-3","article-title":"Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry","volume":"26","author":"Sanchez-Roige","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.semperi.2024.152006_bib0048","article-title":"Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome","author":"Bibi","year":"2022","journal-title":"Pediatr Res"},{"issue":"10-11","key":"10.1016\/j.semperi.2024.152006_bib0049","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1159\/000520296","article-title":"Novel SNX13 frameshift variant in an individual with developmental delay","volume":"161","author":"Tao","year":"2021","journal-title":"Cytogenet Genome Res"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuron.2019.01.016","article-title":"The molecular basis of drug addiction: Linking epigenetic to synaptic and circuit mechanisms","volume":"102","author":"Nestler","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.semperi.2024.152006_bib0051","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/B978-0-444-64076-5.00048-X","article-title":"Neuroepigenetics and addiction","volume":"148","author":"Walker","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"104604","key":"10.1016\/j.semperi.2024.152006_bib0052","article-title":"Adverse childhood experiences, posttraumatic stress, and FKBP5 methylation patterns in postpartum women and their newborn infants","volume":"114","author":"Grasso","year":"2020","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"10.1016\/j.semperi.2024.152006_bib0053","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/nn.3871","article-title":"Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors","volume":"17","author":"Heller","year":"2014","journal-title":"Nat Neurosci"},{"issue":"17","key":"10.1016\/j.semperi.2024.152006_bib0054","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1523\/JNEUROSCI.0013-16.2016","article-title":"Targeted epigenetic remodeling of the Cdk5 gene in nucleus accumbens regulates cocaine- and stress-evoked behavior","volume":"36","author":"Heller","year":"2016","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pain.2012.06.011","article-title":"Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain","volume":"154","author":"Doehring","year":"2013","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0056","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jpeds.2014.05.040","article-title":"Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome","volume":"165","author":"Wachman","year":"2014","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.semperi.2024.152006_bib0057","doi-asserted-by":"crossref","first-page":"e12476","DOI":"10.1111\/gbb.12476","article-title":"Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads","volume":"17","author":"Wachman","year":"2018","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.semperi.2024.152006_bib0058","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2021.12.057","article-title":"Effects of pharmacologic treatment for neonatal abstinence syndrome on DNA methylation and neurobehavior: a prospective cohort study","volume":"243","author":"Camerota","year":"2022","journal-title":"J Pediatr"},{"key":"10.1016\/j.semperi.2024.152006_bib0059","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpeds.2017.07.026","article-title":"Increased DNA methylation of ABCB1, CYP2D6, and OPRM1 genes in newborn infants of methadone-maintained opioid-dependent mothers","volume":"190","author":"McLaughlin","year":"2017","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0060","doi-asserted-by":"crossref","first-page":"17298","DOI":"10.1038\/s41598-024-66899-w","article-title":"DNA methylation patterns in umbilical cord blood from infants of methadone maintained opioid dependent mothers","volume":"14","author":"Adegboyega","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.semperi.2024.152006_bib0061","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0897.2009.00716.x","article-title":"Epigenetics in the placenta","volume":"62","author":"Maccani","year":"2009","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"10.1016\/j.semperi.2024.152006_bib0062","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40572-018-0217-9","article-title":"Adverse maternal metabolic intrauterine environment and placental epigenetics: implications for fetal metabolic programming","volume":"5","author":"Lesseur","year":"2018","journal-title":"Curr Environ Health Rep"},{"key":"10.1016\/j.semperi.2024.152006_bib0063","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fped.2017.00294","article-title":"Opiate drugs with abuse liability hijack the endogenous opioid system to disrupt neuronal and glial maturation in the central nervous system","volume":"5","author":"Hauser","year":"2017","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0064","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4103\/1673-5374.293136","article-title":"Neonatal opioid exposure: public health crisis and novel neuroinflammatory disease","volume":"16","author":"Vasan","year":"2021","journal-title":"Neural Regeneration Res"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.37349\/emed.2020.00009","article-title":"Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study","volume":"1","author":"Wachman","year":"2020","journal-title":"Explor Med"},{"key":"10.1016\/j.semperi.2024.152006_bib0066","doi-asserted-by":"crossref","DOI":"10.1038\/s41372-024-02060-9","article-title":"Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation","author":"Townsel","year":"2024","journal-title":"J Perinatol"},{"issue":"5","key":"10.1016\/j.semperi.2024.152006_bib0067","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051150","article-title":"Effect of prenatal opioid exposure on the human placental methylome","volume":"10","author":"Borrelli","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0068","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ygeno.2021.03.006","article-title":"Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome","volume":"113","author":"Radhakrishna","year":"2021","journal-title":"Genomics"},{"key":"10.1016\/j.semperi.2024.152006_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1292148","article-title":"Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons","volume":"14","author":"Radhakrishna","year":"2024","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0070","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.semperi.2024.152006_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9432965","article-title":"The emerging perspective of morphine tolerance: MicroRNAs","volume":"2019","author":"Zhang","year":"2019","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.semperi.2024.152006_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1215472","article-title":"Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome","volume":"14","author":"Radhakrishna","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.semperi.2024.152006_bib0073","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jpeds.2019.07.032","article-title":"Sex-dependent gene expression in infants with neonatal opioid withdrawal syndrome","volume":"214","author":"Yen","year":"2019","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.semperi.2024.152006_bib0074","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.ygeno.2021.08.001","article-title":"Maternal opioid use disorder: Placental transcriptome analysis for neonatal opioid withdrawal syndrome","volume":"113","author":"Radhakrishna","year":"2021","journal-title":"Genomics"},{"key":"10.1016\/j.semperi.2024.152006_bib0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.placenta.2023.10.001","article-title":"The impact of opioids on the transcriptional landscape of human villous trophoblasts","volume":"143","author":"Sadovsky","year":"2023","journal-title":"Placenta"},{"key":"10.1016\/j.semperi.2024.152006_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114057","article-title":"Effects of prenatal opioid and alcohol exposures on immune and serotonin factors in human placenta","volume":"353","author":"Ruyak","year":"2022","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.semperi.2024.152006_bib0077","doi-asserted-by":"crossref","first-page":"247","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel","article-title":"Animal models of addiction","volume":"19","author":"Spanagel","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0078","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ilar.53.1.4","article-title":"Advancing addiction treatment: what can we learn from animal studies?","volume":"53","author":"Wu","year":"2012","journal-title":"ILAR J"},{"issue":"1","key":"10.1016\/j.semperi.2024.152006_bib0079","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ilar.47.1.39","article-title":"Neonatal animal models of opiate withdrawal","volume":"47","author":"Richardson","year":"2006","journal-title":"ILAR J"},{"issue":"5","key":"10.1016\/j.semperi.2024.152006_bib0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tins.2024.03.005","article-title":"Advances in animal models of prenatal opioid exposure","volume":"47","author":"Ferrante","year":"2024","journal-title":"Trends Neurosci"},{"issue":"109732","key":"10.1016\/j.semperi.2024.152006_bib0081","article-title":"Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice","volume":"240","author":"Borrelli","year":"2023","journal-title":"Neuropharmacology"},{"issue":"18","key":"10.1016\/j.semperi.2024.152006_bib0082","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163266","article-title":"Nucleus accumbens D1\/D2 circuits control opioid withdrawal symptoms in mice","volume":"133","author":"Zhu","year":"2023","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.semperi.2024.152006_bib0083","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/s41386-023-01639-8","article-title":"Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice","volume":"48","author":"Olusakin","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.semperi.2024.152006_bib0084","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.placenta.2020.08.006","article-title":"Maternal oxycodone treatment causes pathophysiological changes in the mouse placenta","volume":"100","author":"Green","year":"2020","journal-title":"Placenta"},{"issue":"11","key":"10.1016\/j.semperi.2024.152006_bib0085","first-page":"18","article-title":"The blood brain barrier and the role of cytokines in neuropsychiatry","volume":"6","author":"Yarlagadda","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.semperi.2024.152006_bib0086","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbi.2019.11.007","article-title":"Prenatal opioid exposure: the next neonatal neuroinflammatory disease","volume":"84","author":"Jantzie","year":"2020","journal-title":"Brain Behav Immun"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000524001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000524001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:20:15Z","timestamp":1739017215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000524001411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0146000524001411"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2024.152006","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of genetics in neonatal abstinence syndrome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2024.152006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152006"}}